Program ICDS 2021

The International Cell Death Society welcomes you to join our upcoming virtual meeting.
“Cell Death in 2021: Looking to the Future “
June 7-10, 2021; 9am-11:30 am EST (GMT -4).
All are welcome, the meeting is free

The meeting will start at 9:00 am each day, and likely conclude at 11:30 am depending on discussions. Invited talks are 20 minutes plus 5 minutes for discussion, while the selected short talks are 10 minutes with 5 minutes for questions and comments. The talks will not be recorded or stored; therefore, only the attendees will have access to the presented information. 

Monday JUNE 7th – 9:00AM-11:30 AM
SESSION 1: Cell death new ideas in therapeutics 

Introduction: Zahra Zakeri, Queens College of CUNY, USA
Chair: Richard A Lockshin, St. John’s Univ., USA
Patrizia Agostinis, Univ. Leuven, Belgium., “Autophagy, a key player of the tumor-stroma dialogue and responses to inflammation”
Peter Vandenabeele, Univ. Ghent, Belgium., “Interaction of ferroptotic cancer cells and the immune system during prophylactic anti-cancer vaccination”
Short Talk – Ozlem Yedier-Bayram, Koç University, Turkey, “Unravelling epigenetic modifiers that regulate therapy resistance in triple negative breast cancer through epigenome-wide knockout screens”
Short Talk – Marietta Zille, Burke Neurological Institute, Weill Cornell Medicine, and University of Lübeck, USA and Germany, “Hemin-induced death models hemorrhagic stroke and is a variant of classical neuronal ferroptosis:

SESSION 2: Cell death and Covid-19

Chair: Zahra Zakeri, Queens College of CUNY, USA
Dror Mevorach, Hadassah – Hebrew University, Medical Center in Jerusalem. Israel., “Covid-19 therapeutics strategies: Regulating the uncontrolled immune response”
Adolfo García-Sastre, Mt. Sinai School of Medicine, USA, “Covid-19 antiviral discovery”

Tuesday JUNE 8th – 9:00AM-11:30 AM
SESSION 3: Mitochondrial Control of Regulated Cell Death

Chair: Jerry Chipuk, Mt. Sinai School of Medicine, USA
Hülya Bayir M.D.; Univ. Pittsburgh, USA., “Mitochondrial Oxidized Phospholipid Signaling in Regulated Cell Death”
Pere Puigserver Ph.D.; Dana-Farber Cancer Inst., USA., “Mechanisms of Mitochondrial Bioenergetic Failures and Cell Death”
Short Talk – Ben Loos, Stellenbosch University, South Africa, “Mitochondrial event localiser (MEL) – a novel tool to quantitatively describe mitochondrial fission, fusion and depolarization”.
Short Talk — Inna Rabinovich-Nikitin, St. Boniface Hospital Albrechtsen Research Centre, Canada, “Mitochondrial autophagy and cell survival is regulated by the circadian clock gene in cardiac myocytes during ischemic stress”
Anne Hamacher-Brady, Ph.D.; Johns Hopkins Univ., USA., “Endolysosomes as Determinants of Mitochondrial Cell Death Signaling”
Luca Scorrano, M.D. Ph.D., Univ. Padua, Italy., “Keeping Mitochondria in Shape: A Matter of Life and Death”

Wednesday JUNE 9th – 9:00AM-11:30 AM
SESSION 4: “Caspases in Cancer; expected and surprising outcomes”

Chair: Sarit Larisch, Univ. Haifa, Israel
Philippe Jost, Medical Univ. Graz, Austria and Technical Univ. Munich, Germany., “Cell death and inflammation in myeloid leukemia”
Eli Arama, Weizmann Institute, Israel., “Inhibition of EMT and cell invasion by sub-lethal levels of caspase activity in Drosophila.”
Short Talk – K. Berthenet, CRCL and Université de Lyon, France, “Failed apoptosis enhances melanoma cancer aggressiveness”
Short Talk – Dana Mamriev, University of Haifa, Israel, “ARTS mimetic small-molecules promote the reversion of pre-malignant breast cells to a normal-like phenotype”
Andreas Bergmann, Univ. Massachusetts Medical School, USA., “Caspase Function in Apoptosis-induced Proliferation”
Dagmar Kulms, University of Dresden, Germany., “Nuclear Caspase-8 promotes progression of p53-proficient tumors.”

Thursday JUNE 10th – 9:00AM-11:30 AM
SESSION 5: “Glorious uncertainties of Life:  Self-eating and Self-preservation”

Chair: Shazib Pervaiz, Univ. Singapore, Singapore
Franck Oury, INSERM/Univ. Paris, France., “Autophagy promotes hippocampal functions and prevents aging-associated cognitive decline”
Matthew Davids, Dana Farber Cancer Institute, USA., “Venetoclax resistance in CLL”
Short Talk – Diede Houbaert, KU Leuven-VIB, Belgium, “The role of lymphatic endothelial autophagy in lymph node T cell trafficking”
Short Talk – Lyndsey Flanagan, RCSI, Dublin, Ireland, “ABT-199 and epigenetic modifiers: promising novel combinations for the treatment of multiple myeloma”
Short Talk – Sahra Aras, Koç University, Turkey, “Regulation of cancer dormancy by microRNAs”
Laura Attardi, Stanford Univ., USA., “Understanding the role of p53-driven cell death in developmental syndromes”

—————–End of the meeting———–